40 articles for G Balboni
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
3,4-Dihydroquinazoline derivatives inhibit the activities of cholinesterase enzymes.

Kyung Hee University
Synthesis and opioid activity of dermorphin tetrapeptides bearing D-methionine S-oxide at position 2.

TBA
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity.

University of Cagliari
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties.

University of Cagliari
Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties.

University of Cagliari
Assessment of substitution in the second pharmacophore of Dmt-Tic analogues.

University of Naples
Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins.

University of Cagliari
Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic.

University of Cagliari
Synthesis of a potent and selective (18)F-labeled delta-opioid receptor antagonist derived from the Dmt-Tic pharmacophore for positron emission tomography imaging.

Stanford University School of Medicine
Role of benzimidazole (Bid) in the delta-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH(2)-Bid (UFP-502).

University of Ferrara
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore.

University of Cagliari
New 2',6'-dimethyl-L-tyrosine (Dmt) opioid peptidomimetics based on the Aba-Gly scaffold. Development of unique mu-opioid receptor ligands.

Vrije Universiteit Brussels
Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties.

University of Cagliary
Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore.

University of Cagliari
Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.

University of Ferrara
Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides.

University of Ferrara
Synthesis and structure-activity relationships of deltorphin analogues.

University of Ferrara
Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues.

TBA
Role of 2',6'-dimethyl-l-tyrosine (Dmt) in some opioid lead compounds.

University of Cagliari
Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffolds.

Vrije Universiteit Brussel
Influence of the side chain next to C-terminal benzimidazole in opioid pseudopeptides containing the Dmt-Tic pharmacophore.

University of Cagliari
Conformationally constrained opioid ligands: the Dmt-Aba and Dmt-Aia versus Dmt-Tic scaffold.

Vrije Universiteit Brussel
Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic.

University of Cagliari
A new opioid designed multiple ligand derived from the micro opioid agonist endomorphin-2 and the delta opioid antagonist pharmacophore Dmt-Tic.

University of Ferrara
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore.

University of Cagliari
New opioid designed multiple ligand from Dmt-Tic and morphinan pharmacophores.

Harvard Medical School
6-N,N-dimethylamino-2,3-naphthalimide: a new environment-sensitive fluorescent probe in delta- and mu-selective opioid peptides.

Universidad De Santiago De Compostela
Conversion of the potent delta-opioid agonist H-Dmt-Tic-NH-CH(2)-bid into delta-opioid antagonists by N(1)-benzimidazole alkylation(1).

University of Cagliari
From the potent and selective mu opioid receptor agonist H-Dmt-d-Arg-Phe-Lys-NH(2) to the potent delta antagonist H-Dmt-Tic-Phe-Lys(Z)-OH.

University of Cagliari
Highly selective fluorescent analogue of the potent delta-opioid receptor antagonist Dmt-Tic.

University of Cagliary
Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.

University of Cagliary
Crystal structures of dipeptides containing the Dmt-Tic pharmacophore.

National Institute of Environmental Health Sciences
Sulfonamide/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors.

University of Firenze
Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors.

University of Cagliari
Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism.

University of Ferrara
Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation.

University of Cagliari
Phe3-substituted analogues of deltorphin C. Spatial conformation and topography of the aromatic ring in peptide recognition by delta opioid receptors.

University of Ferrara
Structural and biological exploration of phe(3)-phe(4)-modified endomorphin-2 peptidomimetics.

University of Milan
Stereospecificity of amino acid side chains in deltorphin defines binding to opioid receptors.

National Institute of Environmental Health Sciences
Piperidine derivatives

Hoffmann-La Roche